Literature DB >> 32373999

Coronavirus disease 2019: a clinical review.

C-L Yang1, X Qiu, Y-K Zeng, M Jiang, H-R Fan, Z-M Zhang.   

Abstract

In December 2019, an outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported in Wuhan, China, and it subsequently spread in many countries around the world. Many efforts have been applied to control and prevent the spread of COVID-19, and many scientific studies have been conducted in a short period of time. Here we present an overview of the viral structure, pathogenesis, diagnosis, and clinical features of COVID-19 based on the current state of knowledge, and we compare its clinical characteristics with SARS and Middle East Respiratory Syndrome (MERS). Current researches on potentially effective treatment alternatives are discussed. We hope this review can help medical workers and researchers around the world contain the current COVID-19 pandemic.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32373999     DOI: 10.26355/eurrev_202004_21045

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  8 in total

1.  Burton's Agammaglobulinemia and COVID-19.

Authors:  Justin G Hovey; Denise Tolbert; Druhan Howell
Journal:  Cureus       Date:  2020-11-25

2.  Tocilizumab for the Treatment of COVID-19-Induced Cytokine Storm and Acute Respiratory Distress Syndrome: A Case Series From a Rural Level 1 Trauma Center in Western Pennsylvania.

Authors:  Krithika Suresh; Michael Figart; Samantha Formeck; Talha Mehmood; Mahmoud Abdel Salam; David Bassilly
Journal:  J Investig Med High Impact Case Rep       Date:  2021 Jan-Dec

Review 3.  Soil pathogens that may potentially cause pandemics, including severe acute respiratory syndrome (SARS) coronaviruses.

Authors:  Joshua J Steffan; Jade A Derby; Eric C Brevik
Journal:  Curr Opin Environ Sci Health       Date:  2020-09-08

4.  Medium Cut-Off Dialysis Membranes: Can They Have Impact on Outcome of COVID-19 Hemodialysis Patients?

Authors:  Serkan Feyyaz Yalın; Mehmet Rıza Altıparmak; Mevlut Tamer Dincer; Serap Yadigar; Ahmet Murt; Ergun Parmaksiz; Claudio Ronco
Journal:  Blood Purif       Date:  2021-01-14       Impact factor: 2.614

5.  COVID-19-Associated Spontaneous Pneumomediastinum and Pneumopericardium: Review of Case Series.

Authors:  Krithika Suresh; Michael W Figart; Talha Mehmood; Asfandyar Butt; Amanpreet Sherwal
Journal:  Cureus       Date:  2021-11-13

6.  Myocardial Injury in COVID-19 Patients: Association with Inflammation, Coagulopathy and In-Hospital Prognosis.

Authors:  Victor Arévalos; Luis Ortega-Paz; Juan José Rodríguez-Arias; Margarita Calvo; Leticia Castrillo; Anthony Salazar; Merce Roque; Ana Paula Dantas; Manel Sabaté; Salvatore Brugaletta
Journal:  J Clin Med       Date:  2021-05-13       Impact factor: 4.241

Review 7.  Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders?

Authors:  Veronica Murta; Alejandro Villarreal; Alberto J Ramos
Journal:  ASN Neuro       Date:  2020 Jan-Dec       Impact factor: 4.146

Review 8.  Race to arsenal COVID-19 therapeutics: Current alarming status and future directions.

Authors:  Ankit Kumar Dubey; Aakansha Singh; Shardendu Prakash; Manoj Kumar; Ashok K Singh
Journal:  Chem Biol Interact       Date:  2020-10-27       Impact factor: 5.192

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.